---
document_datetime: 2023-09-21 20:36:54
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lenalidomide-krka-epar-all-authorised-presentation_en.pdf
document_name: lenalidomide-krka-epar-all-authorised-presentation_en.pdf
version: success
processing_time: 1.6800982
conversion_datetime: 2025-12-24 07:17:22.157473
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging          | Pack size                  |
|------------------|-------------------|------------|-----------------------|---------------------------|------------------------------|----------------------------|
| EU/1/20/1519/001 | Lenalidomide Krka | 2.5 mg     | Capsule, hard         | Oral use                  | blister (OPA/Al/PVC- PET/Al) | 7 x 1 capsule (unit dose)  |
| EU/1/20/1519/002 | Lenalidomide Krka | 2.5 mg     | Capsule, hard         | Oral use                  | blister (OPA/Al/PVC- PET/Al) | 21 x 1 capsule (unit dose) |
| EU/1/20/1519/003 | Lenalidomide Krka | 5 mg       | Capsule, hard         | Oral use                  | blister (OPA/Al/PVC- PET/Al) | 7 x 1 capsule (unit dose)  |
| EU/1/20/1519/004 | Lenalidomide Krka | 5 mg       | Capsule, hard         | Oral use                  | blister (OPA/Al/PVC- PET/Al) | 21 x 1 capsule (unit dose) |
| EU/1/20/1519/005 | Lenalidomide Krka | 7.5 mg     | Capsule, hard         | Oral use                  | blister (OPA/Al/PVC- PET/Al) | 7 x 1 capsule (unit dose)  |
| EU/1/20/1519/006 | Lenalidomide Krka | 7.5 mg     | Capsule, hard         | Oral use                  | blister (OPA/Al/PVC- PET/Al) | 21 x 1 capsule (unit dose) |
| EU/1/20/1519/007 | Lenalidomide Krka | 10 mg      | Capsule, hard         | Oral use                  | blister (OPA/Al/PVC- PET/Al) | 7 x 1 capsule (unit dose)  |
| EU/1/20/1519/008 | Lenalidomide Krka | 10 mg      | Capsule, hard         | Oral use                  | blister (OPA/Al/PVC- PET/Al) | 21 x 1 capsule (unit dose) |
| EU/1/20/1519/009 | Lenalidomide Krka | 15 mg      | Capsule, hard         | Oral use                  | blister (OPA/Al/PVC- PET/Al) | 7 x 1 capsule (unit dose)  |
| EU/1/20/1519/010 | Lenalidomide Krka | 15 mg      | Capsule, hard         | Oral use                  | blister (OPA/Al/PVC- PET/Al) | 21 x1 capsule (unit dose)  |
| EU/1/20/1519/011 | Lenalidomide Krka | 20 mg      | Capsule, hard         | Oral use                  | blister (OPA/Al/PVC- PET/Al) | 7 x 1 capsule (unit dose)  |
| EU/1/20/1519/012 | Lenalidomide Krka | 20 mg      | Capsule, hard         | Oral use                  | blister (OPA/Al/PVC- PET/Al) | 21 x 1 capsule (unit dose) |
| EU/1/20/1519/013 | Lenalidomide Krka | 25 mg      | Capsule, hard         | Oral use                  | blister (OPA/Al/PVC- PET/Al) | 7 x 1 capsule (unit dose)  |
| EU/1/20/1519/014 | Lenalidomide Krka | 25 mg      | Capsule, hard         | Oral use                  | blister (OPA/Al/PVC- PET/Al) | 21 x 1 capsule (unit dose) |